Ofatumumab in combination with high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia.
Januario E. Castro
No relevant relationships to disclose
Michael Y. Choi
No relevant relationships to disclose
Tomas Carvajal
No relevant relationships to disclose
Hongying Li
No relevant relationships to disclose
Danelle Frances James
No relevant relationships to disclose
Karen Messer
No relevant relationships to disclose
Thomas J. Kipps
No relevant relationships to disclose